BIONIK LABORATORIES CORP. (OTCMKTS:BNKL) Files An 8-K Regulation FD Disclosure

0

BIONIK LABORATORIES CORP. (OTCMKTS:BNKL) Files An 8-K Regulation FD Disclosure

Item 7.01

Regulation FD Disclosure
On June 6, 2017, Bionik Laboratories Corp. (the Registrant)
issued a press release announcing that Peter Bloch, its Chief
Executive Officer, will present at the 6th Annual 2017 Marcum
MicroCap Conference on Friday, June 16, 2017 at 11:00 am ET. The
conference will be held at The Grand Hyatt Hotel in New York
City.
During his presentation, Mr. Bloch will provide a corporate
update and discuss the Registrants propriety assistive robotic
therapy systems that are commercially available for treatment of
stroke and other neurological disorders, as well as new products
currently under development.
A copy of the press release is furnished as Exhibit 99.1 to this
Current Report on Form 8-K and is incorporated herein by
reference. The information in this report (including Exhibit
99.1) is being furnished to Item 7.01 and shall not be deemed to
be filed for the purposes of Section 18 of the Securities
Exchange Act of 1934, as amended, or otherwise subject to the
liabilities of that section. This report will not be deemed an
admission as to the materiality of any information herein
(including Exhibit 99.1).
Item 9.01
Financial Statements and Exhibits
(d) Exhibits.
Exhibit
Description
99.1
Press Release


About BIONIK LABORATORIES CORP. (OTCMKTS:BNKL)

Bionik Laboratories Corp. (Bionik), formerly Drywave Technologies, Inc., is a medical device and robotics company. The Company is focused on providing rehabilitation solutions and developing transformational technologies and solutions to individuals with neurological disorders, specializing in the designing, developing and commercializing of physical rehabilitation technologies, prosthetics and assisted robotic products. It has over three products on the market and approximately three products in various stages of development. The InMotion Systems include the InMotion ARM, InMotion HAND, InMotion Wrist and InMotion ANKLE are designed to provide patent-adaptive therapy in a manner that has been clinically verified to manage neuro-recovery. The Company is also engaged in developing a lower-body exoskeleton, ARKE, which designs to allow paraplegics, as well as other wheelchair users the ability to rehabilitate through walking.